PHS CONFLICT-OF-INTEREST PROPOSAL MANDATES DISCLOSURE OF INTERESTS OVER $5,000
This article was originally published in The Gray Sheet
Executive Summary
PHS CONFLICT-OF-INTEREST PROPOSAL MANDATES DISCLOSURE OF INTERESTS OVER $5,000 or exceeding 5% in any entity "that would reasonably appear to be directly and significantly affected" by Public Health Service-funded research. The proposed rule was published in the June 28 Federal Register and addresses responsibilities of individuals and institutions to disclose financial interests that may impinge upon the objectivity of PHS- supported research. It is open to public comment through Aug. 29.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.